27 Mar 2024
26 March 2024: Trilegal represented MEMG Family Office LLP (MEMG LLP) and 360 One Private Equity Fund (360 One) in securing an unconditional approval from the Competition Commission of India (CCI) in relation to the proposed subscription of compulsorily convertible preference shares in API Holdings Limited (API). The CCI approved the transaction on 26 March 2024.
Trilegal represented MEMG LLP and 360 One on the Indian competition law aspects of the transaction and filed a merger notification with the CCI. Trilegal demonstrated that the proposed transaction would not cause any appreciable adverse effect on competition in any of the relevant markets in India.
MEMG LLP, incorporated in India, is part of the Manipal Education and Medical Group. 360 One is a Securities and Exchange Board of India (SEBI) registered fund, established for undertaking investment activities in India and abroad. API is engaged in various activities in the pharmaceutical and healthcare sector in India and owns the ‘Pharmeasy’ platform.
Trilegal competition team was led by Nisha Kaur Uberoi, Partner & National Head – Competition Law and Rudresh Singh, Partner; and assisted by Anand Sree, Senior Associate; Kamal Sharma, Senior Associate; Vasudha Verma, Shaurya Kashyap and Mehar Singh Dang, Associates.
For more information, please contact:
Roomi Irani
Mob: +91-2240791000 | BD@trilegal.com
Trilegal expands its Intellectual Property practice with the addition of two new Partners
Deal: Trilegal advised Indus Infra Trust on its Institutional Placement (IP) and preferential allotment aggregating to approximately INR 2,000 crore First institutional placement by a road InvIT for the acquisition of third-party assets
Deal: Trilegal advises Kimbal on its Series B fundraise from GEF Capital Partners and Niveshaay Sambhav Fund
Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:
We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:
For more information, please read our terms of use and our privacy policy.
